Sulfaguanidine
規格
57-67-0CAS番号
200-345-9EC番号
2-(4-aminophenyl)sulfonylguanidineIUPAC名
C7H10N4O2S化学式
214.25 g/mol分子量
sulfaguanidine; 57-67-0; Sulphaguanidine; Sulfaguanidin; Sulfaguine; Sulfanilylguanidine; Sulfanilguanidine; Sulfaguanil; Sulfoguanidine; Sulfoguanil; Sulfoguanyl; 2-(4-aminophenyl)sulfonylguanidine; Sulfaguanidina; Sulfaguanidinum; Benzenesulfonamide, 4-amino-N-(aminoiminomethyl)-; Sulginum; DTXSID1023609; NSC-14041; 2-sulfanilylguanidine; CHEBI:94621; 15XQ8043FN; DTXCID103609; Guanimycin; Veto centre; Veto-centre; Gppe susp fte; RefChem:186486; GastroEntericanis Biocanina; Gastro Entericanis Biocanina; Gastro-Entericanis Biocanina; A07AB03; 200-345-9; Guanicil; Aterian; Guamide; Abiguanil; Guanidan; Sulfentidine; Ganidan; Sulgin; N1-Amidinosulfanilamide; Orgaguanidon; Sulfoguenil; Sulfoquanidine; Resulfon; Suganyl; Diacta; Ruocid; N-Guanylsulfanilamide; S-Guanidine; 1-Sulfanilylguanidine; 4-Amino-N-(aminoiminomethyl)benzenesulfonamide; Shigatox; Guanidine, sulfanilyl-; p-Aminobenzenesulfonylguanidine; p-Aminobenzenesulfoguanidide; RP 2275; 4-amino-N-carbamimidoylbenzenesulfonamide; Sulfanilamide, n(sup1)-amidino-; ((p-Aminophenyl)sulfonyl)guanidine; Sulfanilamide, N1-amidino-; ((4-Aminophenyl)sulfonyl)guanidine; Sulfaguanidine [INN]; 1-((p-Aminophenyl)sulfonyl)guanidine; Sulfaguamidine; 4-Amino-N-(diaminomethylene)benzenesulfonamide; A-307; N-p-Aminobenzenesulphonylguanidine monohydrate; 4-Aminobenzenesulfonylguanidine; 61116-95-8; Emerin (pharmaceutical); 1-(4-aminophenyl)sulfonylguanidine; N-(4-aminobenzenesulfonyl)guanidine; Benzenesulfonamide, 4-amino-N-(diaminomethylene)-; CHEMBL338802; Sulfaguanidine (INN); CAS-57-67-0; NCGC00016252-01; Solfaguanidina; amino[(4-aminophenyl)sulfonyl]carboxamidine; 4-Amino-N-carbamimidoylbenzene-1-sulfonamide; 4-Amino-N-diaminomethylene-benzenesulfonamide; 4-amino-N-(diaminomethylidene)benzenesulfonamide; Solfaguanidina [DCIT]; [(p-Aminophenyl)sulfonyl]guanidine; [(4-Aminophenyl)sulfonyl]guanidine; 1-[(p-Aminophenyl)sulfonyl]guanidine; Sulfaguanidinum [INN-Latin]; N(sup 1)-Guanylsulfanilamide; Sulfaguanidina [INN-Spanish]; N(sup 1)-Amidinosulfanilamide; Emerin (pharmaceutical) (VAN); N1-Guanylsulfanilamide; SR-01000000167; EINECS 200-345-9; NSC 14041; 4-amino-N-[amino(imino)methyl]benzenesulfonamide; {[amino(imino)methyl]amino}(4-aminophenyl)dioxo-lambda~6~-sulfane; N(sup1)-Guanylsulfanilamide; ulfaguanidine; N(sup1)-Amidinosulfanilamide; N(sup 1)-(Diaminomethylene)sulfanilamide; UNII-15XQ8043FN; Sulfaguanidine [INN:BAN:NF]; AI3-01048; Sulfaguanidine CRS; 4-Amino-N-amidinobenzenesulfonamide; Sulfanilamide, N(sup 1)-amidino-; Sulfanilyl guanidine; Prestwick_429; MFCD00038136; Spectrum_001412; N1-Guanidylsulfanilamide; N-1-Amidinosulfanilamide; WLN: ZR DSWMYZUM; Prestwick0_000010; Prestwick1_000010; Prestwick2_000010; Prestwick3_000010; Spectrum2_001420; Spectrum3_001456; Spectrum4_000429; Spectrum5_001197; Sulfaguanidine (Standard); Epitope ID:952463; SULFAGUANIDINE [MI]; SCHEMBL93639; 4-aminophenylsulfonylguanidine; BSPBio_000019; BSPBio_002951; KBioGR_000758; KBioSS_001892; MLS000069712; DivK1c_000633; SPECTRUM1501146; SPBio_001500; SPBio_001940; aniline, 4-guanidinosulphonyl-; SULFAGUANIDINE [MART.]; BPBio1_000021; orb1224612; orb1310542; SCHEMBL1650003; SULFAGUANIDINE [WHO-DD]; GTPL12639; HMS501P15; HY-B1267R; KBio1_000633; KBio2_001892; KBio2_004460; KBio2_007028; KBio3_002451; MSK4043; NINDS_000633; HMS1568A21; HMS1921J19; HMS2092H05; HMS2095A21; HMS3652J05; HMS3712A21; HMS5082P04; Pharmakon1600-01501146; ALBB-035791; HY-B1267; NSC14041; SULFAGUANIDINE [EP IMPURITY]; Tox21_110329; BDBM50027795; CCG-38973; EBC-02027; EBC-44036; NSC757861; s4175; SBB006522; STK031666; STK064640; SULFAGUANIDINE [EP MONOGRAPH]; AKOS000121440; AKOS000319495; MSK4043-1000M; N''-(4-aminobenzenesulfonyl)guanidine; Sulfanilamide, N1-(diaminomethylene)-; Tox21_110329_1; 2-[(4-Aminobenzene)sulfonyl]guanidine; CS-4677; DB13726; NSC-757861; IDI1_000633; SMP1_000283; NCGC00018234-01; NCGC00018234-02; NCGC00018234-03; NCGC00018234-04; NCGC00018234-05; NCGC00018234-07; NCGC00024191-03; NCGC00024191-04; AC-10943; DA-58168; SMR000058191; ST057626; SBI-0051658.P002; SBI-0051658.P003; DB-291822; AB00052220; NS00000003; SULFADIAZINE IMPURITY C [EP IMPURITY]; SW196658-2; EN300-34321; SULFADIMIDINE IMPURITY C [EP IMPURITY]; D02437; F85238; Sulfaguanidine 1000 microg/mL in Acetonitrile; AB00052220_15; AB00052220_16; Sulfaguanidine Solution in Methanol, 1000ug/mL; 4-amino-N-(amino-imino-methyl)-benzenesulfonamide; 8R-0841; F863913; Q414886; Sulfaguanidine, VETRANAL(TM), analytical standard; 1N-amino(imino)methyl-4-amino-1-benzenesulfonamide; SR-01000000167-2; SR-01000000167-3; SR-01000000167-4; 4-amino-N-[(E)-amino(imino)methyl]benzenesulfonamide; 4-amino-N-[(Z)-amino(imino)methyl]benzenesulfonamide; BRD-K45086103-001-14-8; BRD-K45086103-001-15-5; BRD-K45086103-001-16-3; Z56758608; 1-Amino-4-(([amino(imino)methyl]amino)sulfonyl)benzene #; Sulfaguanidine, European Pharmacopoeia (EP) Reference Standard; 2-[(dioxidosulfanyl)amino]-1,9-dihydro-6H-purin-6-one[sulfaguanine]; Sulfaguanidine; Sulfadiazine EP Impurity C; Sulfadimidine EP Impurity C; QA9別名
Sulfaguanidineを含む製品
Sulfaguanidineを販売する企業
IM
Inner Mongolia Bolin Pharmaceutical Co. LTDChinaAC
AFINE CHEMICALS LIMITEDLZ
Luoyang Zhengmu Bio-Tech Co., Ltd.China